Global Market Access

Navigating Global Healthcare Markets with Syenza’s Expertise

Access Beyond Borders

We're inspired by dynamic and diverse global healthcare markets. As a leading value science company, Syenza supports market access activities with global intelligence and local understanding of pricing, reimbursement, and patients. Our philosophy is to drive efficiences through early engagement with payors and decision-makers to increase the probability of success.

GLOBAL MARKET ACCESS

Global Market Access Strategy

Syenza enables clients to execute on opportunities by evaluating the market access landscape, analysing current payor reimbursement policies, generating pricing insights, developing an optimized market access strategy, and deploying evidence to support access to innovations.

Outsourced Global Market Access

Syenza provides an Embedded Market Access Team (EMAT) where our interdisciplinary professionals boost capacity with rapid evidence reviews, localized cost breakdowns, stakeholder outreach, training, and market/ competitor scanning.

Value-based Contracting

Syenza scenario builds different approaches to value-based contracting based on demonstrable real-world evidence of the clinical and economic value. Our in-market insights and relationships add depth and nuance to each scenario and improves overall decision-making.

Service Outcomes

Clients receive actionable insights
in Market Access Landscape Reports, Comparative Pricing Reports, and Value-Positioning Workshops.

Clients fill capacity gaps in market access organizations with EMAT to enhance launch and post-launch activities.

Clients apply in-market insights to develop value-based contracts that support access to innovations in different markets.

View Our Recent Case Study

Biopharmaceutical Market Access Analysis in Dubai

August 23, 2022

Objective : A market access landscape analysis is the first step to improving access in the target countries. This involved identifying the unmet need in the disease area, audiences with which to build a shared agenda, and shaping national reimbursem

Read More

VIEW ALL

View Our Recent Articles

Health Misinformation Autism: The Dangers of Politicized...

🤔 Are you aware of how political narratives shape public perceptions of health misinformation? In a recent BMJ article, it’s revealed that certain ideological movements are driving false claims about autism,...

João L. Carapinha
3 weeks ago
Read More
The Market Dynamics of Track One Patent Strategy in...

🌟 Curious about how pharmaceutical companies strategically use Track One patents? Our latest review article explores the USPTO's Track One program, noting that nearly half of these patents are continuation...

Rene Pretorius
1 month ago
Read More
Ending Unproven Fertility Treatments: NICE Calls for...

🌱 Are you or someone you know navigating the complex world of fertility treatments? The recent guidance from the National Institute for Health and Care Excellence (NICE) is shaking up the landscape of...

João L. Carapinha
1 month ago
Read More
VIEW ALL